Shaochuan Liu

anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells

Shaochuan Liu, Tingting Qin, Zhujun Liu et al. · Cell Death and Disease · 2020 · 186 citations · Full text

Medicine, Immunology, Oncology +17

Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling

Tingting Qin, Zhujun Liu, Jing Wang et al. · Cancer Biology and Medicine · 2020 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer

Junyi Li, Yuanjie Cao, Yan‐Cheng Liu et al. · Journal for ImmunoTherapy of Cancer · 2024 · 47 citations · Full text

Medicine, Immunology, Oncology +17

CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer

Shaochuan Liu, Yuan Meng, Liang Liu et al. · Cell Death and Disease · 2022 · 44 citations · Full text

Life Sciences, Immunology, Oncology +17

Effect of bevacizumab on the tight junction proteins of vascular endothelial cells.

Yanan Jia, Tingting Qin, Xiaoling Zhang et al. · PubMed · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17